Chabiotech Co.,Ltd. (085660.KQ)
KRW 15280.0
(-2.98%)
KRW 15280.0
(-2.98%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 449.63 Billion KRW | 12.17% |
| 2022 | 400.85 Billion KRW | 20.08% |
| 2021 | 333.83 Billion KRW | 9.0% |
| 2020 | 306.26 Billion KRW | 36.91% |
| 2019 | 223.7 Billion KRW | 70.77% |
| 2018 | 130.99 Billion KRW | 21.7% |
| 2017 | 107.64 Billion KRW | -48.7% |
| 2016 | 209.81 Billion KRW | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 499.96 Billion KRW | 9.02% |
| 2024 Q1 | 460.5 Billion KRW | 2.42% |
| 2023 Q1 | 447.28 Billion KRW | 11.58% |
| 2023 FY | 449.63 Billion KRW | 12.17% |
| 2023 Q4 | 449.63 Billion KRW | -6.13% |
| 2023 Q3 | 479 Billion KRW | 4.88% |
| 2023 Q2 | 456.73 Billion KRW | 2.11% |
| 2022 Q2 | 378.33 Billion KRW | 4.61% |
| 2022 Q4 | 400.85 Billion KRW | -8.72% |
| 2022 Q3 | 439.13 Billion KRW | 16.07% |
| 2022 FY | 400.85 Billion KRW | 20.08% |
| 2022 Q1 | 361.66 Billion KRW | 8.34% |
| 2021 Q3 | 333.17 Billion KRW | 0.0% |
| 2021 Q4 | 333.83 Billion KRW | 0.2% |
| 2021 FY | 333.83 Billion KRW | 9.0% |
| 2020 FY | 306.26 Billion KRW | 36.91% |
| 2019 FY | 223.7 Billion KRW | 70.77% |
| 2018 FY | 130.99 Billion KRW | 21.7% |
| 2017 FY | 107.64 Billion KRW | -48.7% |
| 2016 FY | 209.81 Billion KRW | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| HLB Co., Ltd. | 62.7 Billion KRW | -617.059% |
| iNtRON Biotechnology, Inc. | 402.9 Million KRW | -111497.062% |
| BINEX Co., Ltd. | 53.5 Billion KRW | -740.328% |
| Bioneer Corporation | 44.63 Billion KRW | -907.25% |
| Anterogen.Co.,Ltd. | 9.74 Billion KRW | -4516.188% |
| MEDIPOST Co., Ltd. | 52.33 Billion KRW | -759.103% |
| CrystalGenomics, Inc. | 32 Billion USD | -1304.971% |
| Helixmith Co., Ltd | 20.22 Billion KRW | -2122.866% |
| Medy-Tox Inc. | 82.83 Billion KRW | -442.84% |
| Peptron, Inc. | 9.13 Billion KRW | -4823.2% |
| Amicogen, Inc. | 149.59 Billion KRW | -200.568% |
| Genexine, Inc. | 67.42 Billion KRW | -566.846% |
| HLB Therapeutics Co.,Ltd. | 10.02 Billion KRW | -4386.326% |
| LegoChem Biosciences, Inc. | 12.64 Billion KRW | -3456.133% |
| ALTEOGEN Inc. | 83.76 Billion KRW | -436.755% |
| PharmaResearch Co., Ltd. | 34.3 Billion KRW | -1210.634% |
| SillaJen, Inc. | 9.69 Billion KRW | -4537.031% |
| JETEMA, Co., Ltd. | 130.49 Billion KRW | -244.556% |
| OliX Pharmaceuticals,Inc | 39.35 Billion KRW | -1042.443% |
| Genomictree Inc. | 1.83 Billion KRW | -24407.852% |
| MedPacto, Inc. | 8.6 Billion KRW | -5125.815% |
| D&D Pharmatech | 8.13 Billion KRW | -5427.643% |
| EASY BIO,Inc. | 82.27 Billion KRW | -446.483% |
| GI Innovation, Inc. | 3.72 Billion KRW | -11984.265% |